Changela Kinesh, Ona Mel A, Anand Sury, Duddempudi Sushil
Department of Gastroenterology, The Brooklyn Hospital Center, New York, United States.
Endosc Int Open. 2014 Dec;2(4):E244-51. doi: 10.1055/s-0034-1377980. Epub 2014 Oct 24.
Acute variceal bleeding (AVB) is a life-threatening complication of liver cirrhosis or less commonly splenic vein thrombosis. Pharmacological and endoscopic interventions are cornerstones in the management of variceal bleeding but may fail in 10 - 15 % of patients. Rescue therapy with balloon tamponade (BT) or transjugular intrahepatic portosystemic shunt (TIPS) may be required to control refractory acute variceal bleeding effectively but with some limitations. The self-expanding metal stent (SEMS) is a covered, removable tool that can be deployed in the lower esophagus under endoscopic guidance as a rescue therapy to achieve hemostasis for refractory AVB.
To evaluate the technical feasibility, efficacy, and safety of SEMS as a rescue therapy for AVB.
In this review article, we have performed an extensive literature search summarizing case reports and case series describing SEMS as a rescue therapy for AVB. Indications, features, technique, deployment, success rate, limitations, and complications are discussed.
At present, 103 cases have been described in the literature. Studies have reported 97.08 % technical success rates in deployment of SEMS. Most of the stents were intact for 4 - 14 days with no major complications reported. Stent extraction had a success rate of 100 %. Successful hemostasis was achieved in 96 % of cases with only 3.12 % found to have rebleeding after placement of SEMS. Stent migration, which was the most common complication, was observed in 21 % of patients.
SEMS is a safe and effective alternative approach as a rescue therapy for refractory AVB.
急性静脉曲张出血(AVB)是肝硬化或较少见的脾静脉血栓形成的一种危及生命的并发症。药物和内镜干预是静脉曲张出血管理的基石,但在10%-15%的患者中可能失败。可能需要用球囊压迫(BT)或经颈静脉肝内门体分流术(TIPS)进行挽救治疗,以有效控制难治性急性静脉曲张出血,但存在一些局限性。自膨式金属支架(SEMS)是一种有覆膜的、可移除的工具,可在内镜引导下放置于食管下段,作为一种挽救治疗手段,为难治性AVB实现止血。
评估SEMS作为AVB挽救治疗的技术可行性、有效性和安全性。
在这篇综述文章中,我们进行了广泛的文献检索,总结了将SEMS描述为AVB挽救治疗的病例报告和病例系列。讨论了适应证、特点、技术、放置、成功率、局限性和并发症。
目前,文献中已描述了103例病例。研究报告SEMS放置的技术成功率为97.08%。大多数支架在4-14天内保持完好,未报告重大并发症。支架取出成功率为100%。96%的病例实现了成功止血,SEMS放置后仅有3.12%的病例出现再出血。支架移位是最常见的并发症,在21%的患者中观察到。
SEMS作为难治性AVB的挽救治疗是一种安全有效的替代方法。